Esperion Therapeutics (ESPR) Stock Chart & Stock Price History → [URGENT] DO NOT Touch These AI Stocks! (From Weiss Ratings) (Ad) Free ESPR Stock Alerts $2.36 -0.23 (-8.88%) (As of 05/17/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Esperion Therapeutics Stock Price Performance5 Day Performance+8.26%1 Month Performance+21.03%3 Month Performance-12.27%6 Month Performance+98.32%Year-To-Date Performance-21.07%1 Year Performance+43.90% Receive ESPR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Esperion Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad The Freeport SocietyBiden Nomination CANCELED?The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words?I believe I have the terrifying answer right here. ESPR Stock Chart for Sunday, May, 19, 2024 ESPR Chart by TradingView Esperion Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$2.59$2.36-8.88%$2.60$2.338.18 million shs$447.13 million05/16/2024$2.30$2.59+12.61%$2.60$2.2810.78 million shs$490.70 million05/15/2024$2.18$2.30+5.50%$2.32$2.146.96 million shs$435.76 million05/14/2024$2.23$2.18-2.24%$2.30$2.144.57 million shs$413.02 million05/13/2024$2.19$2.23+1.83%$2.32$2.174.42 million shs$422.50 million05/10/2024$2.09$2.19+4.78%$2.22$2.079.42 million shs$414.79 million Get the Latest News and Ratings for ESPR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Esperion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$2.04$2.09+2.45%$2.19$2.067.46 million shs$395.85 million05/08/2024$2.37$2.04-13.92%$2.30$2.0113.72 million shs$386.38 million05/07/2024$2.12$2.37+11.79%$2.53$2.1345.84 million shs$448.88 million05/06/2024$2.08$2.12+1.92%$2.18$2.046.75 million shs$401.53 million05/03/2024$2.06$2.08+0.97%$2.21$2.045.45 million shs$393.95 million05/02/2024$2.04$2.06+0.98%$2.12$2.032.87 million shs$390.16 million05/01/2024$1.97$2.04+3.55%$2.12$1.942.99 million shs$386.38 million04/30/2024$1.99$1.97-1.01%$2.04$1.942.34 million shs$373.12 million04/29/2024$1.90$1.99+4.74%$2.02$1.883.86 million shs$376.91 million04/26/2024$1.99$1.90-4.52%$2.01$1.884.20 million shs$359.86 million04/25/2024$2.13$1.99-6.57%$2.10$1.955.06 million shs$376.91 million04/24/2024$2.09$2.13+1.91%$2.16$2.065.43 million shs$403.42 million04/23/2024$1.91$2.09+9.42%$2.13$1.934.94 million shs$395.85 million04/22/2024$1.95$1.91-2.05%$1.96$1.844.79 million shs$361.75 million04/19/2024$1.87$1.95+4.28%$1.97$1.717.35 million shs$369.33 million04/18/2024$1.84$1.87+1.63%$2.03$1.816.02 million shs$354.18 million04/17/2024$1.91$1.84-3.66%$1.96$1.813.71 million shs$348.50 million04/16/2024$1.94$1.91-1.29%$1.99$1.846.18 million shs$361.75 million04/15/2024$2.14$1.94-9.58%$2.13$1.936.82 million shs$366.49 million04/12/2024$2.31$2.14-7.36%$2.42$2.047.53 million shs$396.01 million04/11/2024$2.52$2.31-8.33%$2.54$2.258.80 million shs$427.47 million04/10/2024$2.79$2.52-9.68%$2.72$2.458.97 million shs$466.33 million04/09/2024$3.03$2.79-7.92%$3.17$2.765.75 million shs$516.29 million04/08/2024$3.24$3.03-6.48%$3.40$2.907.89 million shs$560.70 million04/05/2024$3.11$3.24+4.18%$3.40$3.0210.43 million shs$599.57 million04/04/2024$3.12$3.11-0.32%$3.40$3.0311.29 million shs$575.51 million04/03/2024$2.88$3.12+8.33%$3.33$2.9021.18 million shs$577.36 million04/02/2024$2.79$2.88+3.23%$3.01$2.696.30 million shs$532.94 million04/01/2024$2.68$2.79+4.10%$2.88$2.637.36 million shs$516.29 million03/29/2024$2.68$2.68$2.80$2.548.25 million shs$495.93 million03/28/2024$2.62$2.68+2.29%$2.80$2.548.18 million shs$495.93 million03/27/2024$2.70$2.62-2.96%$2.80$2.5211.94 million shs$484.83 million03/26/2024$2.62$2.70+3.05%$2.96$2.5614.73 million shs$499.64 million03/25/2024$2.29$2.62+14.41%$2.76$2.3127.39 million shs$484.84 millionElon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it.03/22/2024$2.11$2.29+8.53%$2.40$2.109.27 million shs$423.76 million03/21/2024$2.19$2.11-3.65%$2.24$2.064.54 million shs$390.46 million03/20/2024$2.08$2.19+5.29%$2.21$2.022.60 million shs$405.27 million03/19/2024$2.05$2.08+1.46%$2.21$2.013.95 million shs$384.90 million03/18/2024$2.07$2.05-0.97%$2.13$2.004.24 million shs$379.35 million03/15/2024$2.05$2.07+0.98%$2.15$1.9210.73 million shs$383.06 million03/14/2024$2.19$2.05-6.39%$2.25$2.015.61 million shs$379.35 million03/13/2024$2.05$2.19+6.83%$2.21$2.041.81 million shs$405.26 million03/12/2024$2.12$2.05-3.30%$2.15$2.042.42 million shs$379.35 million03/11/2024$2.19$2.12-3.20%$2.20$2.102.86 million shs$392.31 million03/08/2024$2.28$2.19-3.95%$2.30$2.183.18 million shs$405.26 million03/07/2024$2.46$2.28-7.32%$2.44$2.194.74 million shs$259.28 million03/06/2024$2.40$2.46+2.50%$2.52$2.372.12 million shs$279.75 million03/05/2024$2.44$2.40-1.64%$2.53$2.332.83 million shs$272.93 million03/04/2024$2.55$2.44-4.31%$2.61$2.363.23 million shs$277.48 million03/01/2024$2.51$2.55+1.59%$2.56$2.452.97 million shs$289.99 million02/29/2024$2.57$2.51-2.33%$2.74$2.493.27 million shs$285.44 million02/28/2024$2.90$2.57-11.38%$3.03$2.506.86 million shs$292.26 million02/27/2024$2.63$2.90+10.27%$3.00$2.399.89 million shs$329.79 million02/26/2024$2.61$2.63+0.77%$2.78$2.614.94 million shs$299.08 million02/23/2024$2.63$2.61-0.76%$2.68$2.503.51 million shs$296.81 million02/22/2024$2.61$2.63+0.77%$2.71$2.612.51 million shs$299.08 million02/21/2024$2.68$2.61-2.61%$2.69$2.524.62 million shs$296.80 million02/20/2024$2.69$2.68-0.37%$3.03$2.645.23 million shs$304.77 million02/19/2024$2.69$2.69$2.79$2.624.78 million shs$305.91 million Related Companies: Mereo BioPharma Group Stock Chart Neurogene Stock Chart Shattuck Labs Stock Chart Heron Therapeutics Stock Chart Verrica Pharmaceuticals Stock Chart Korro Bio Stock Chart Terns Pharmaceuticals Stock Chart Annexon Stock Chart Biomea Fusion Stock Chart Alto Neuroscience Stock Chart Receive ESPR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Esperion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ESPR) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingBuy this small stock before coming AI Tidal WaveChaikin AnalyticsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersUrgent Nvidia WarningAltimetry41 banks launch ‘crypto dollar’Stansberry ResearchMost important medical advance in 100 yearsThe Oxford ClubForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Esperion Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.